Previous 10 | Next 10 |
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Receive $1.0 Million Milestone Payment from Eurofarma Milestone Based on Achievement of Patient Enrolment Target in Phase 3 Clinical Trials of Ridinilazole Oxford, UK...
SINGAPORE / ACCESSWIRE / February 5, 2020 / Jadestone Energy Inc. (AIM:JSE, TSXV:JSE) ("Jadestone" or the "Company"), an independent oil and gas production company focused on the Asia Pacific region, announces that on February 5, 2020, Cedric Fontenit, a Non-executive Director of Jadestone, ...
OCALA, FL / ACCESSWIRE / February 5, 2020 / AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, today announced posting by the University of Pittsburgh Medical Center (UPMC) on January ...
CALGARY, Alberta, Feb. 05, 2020 (GLOBE NEWSWIRE) -- This Announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 (“MAR”). Upon the publication of this Announcement, this inside information is now considered to be in the ...
Horizon Discovery Group plc Pre-Close Trading Update Full year 2019 Group unaudited revenues from continuing operations expected to increase by approximately 8% to approximately £58.3 million Full year 2019 Group unaudited reported revenues expected to increase by...
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Present at the 2020 BIO CEO & Investor Conference Oxford, UK, and Cambridge, MA, US, 4 February 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announc...
With another choppy market session in the books, investors remain focused on small-cap stocks. Also known as penny stocks , these low-priced equities tend to perform well during times of both market uncertainty and stagnation. This time around we might be seeing both. During the last 6 sessions...
LONDON and VANCOUVER, British Columbia, Feb. 03, 2020 (GLOBE NEWSWIRE) -- In response to certain questions from the British Columbia Securities Commission (the “ BSCS ”), Mkango Resources Ltd. (AIM/TSX-V: MKA) (the "Company") has today filed a revised NI 43-101 Report (the ...
Dr. David Zaccardelli appointed President and Chief Executive Officer Mark W. Hahn appointed Chief Financial Officer LONDON, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company fo...
ST. LOUIS and LONDON, Jan. 31, 2020 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) is pleased to announce that its European subsidiary, Stifel Nicolaus Europe Limited (“Stifel Europe”), was ranked among the top investment banks in UK equity capital markets for activity ...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...